Description

BSE lists 500 units of Commercial Paper issued by Fedbank Financial Services Limited on private placement basis, effective December 1, 2025.

Summary

BSE has listed new Commercial Paper issued by Fedbank Financial Services Limited on private placement basis. The instrument consists of 500 units with a face value of Rs. 5,00,000 each, listed under Scrip Code 730674 (FFSL281125) with ISIN INE007N14EL2. Trading commenced on December 1, 2025, in dematerialized form only.

Key Points

  • 500 units of Commercial Paper listed on BSE Debt segment
  • Face value: Rs. 5,00,000 per unit
  • Issue price: Rs. 4,91,688.50 per unit
  • Credit rating: CRISIL A1+, ICRA A1+
  • Scrip Code: 730674, Scrip ID: FFSL281125
  • ISIN: INE007N14EL2
  • Market lot: 1 unit
  • Tick size: 1 paise
  • Issuing and Paying Agent: Federal Bank Limited
  • Trading in dematerialized form only
  • Standard denomination: Rs. 5 Lakhs and multiples thereof

Regulatory Changes

No regulatory changes introduced. This is a standard debt instrument listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form
  • Trading must be conducted in standard denomination of Rs. 5 Lakhs and multiples
  • Securities must be traded under ISIN INE007N14EL2

Important Dates

  • Notice Date: December 1, 2025
  • Listing Date: December 1, 2025 (effective from today)
  • Date of Allotment: November 28, 2025
  • Date of Redemption: February 27, 2026

Impact Assessment

Market Impact: Minimal. This is a routine commercial paper listing in the debt segment affecting only debt market participants.

Operational Impact: Low. Trading members dealing in debt instruments need to note the instrument specifications for trading purposes. Standard procedures apply for dematerialized trading.

Investor Impact: Limited to institutional investors participating in commercial paper markets. The instrument has high credit ratings (A1+ from both CRISIL and ICRA), indicating strong short-term credit quality.

Impact Justification

Routine commercial paper listing with no impact on equity markets or broader regulatory changes